tosyllysine chloromethyl ketone and Hypertension, Pulmonary

tosyllysine chloromethyl ketone has been researched along with Hypertension, Pulmonary in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
MacLean, MR; Murray, F; Pyne, NJ1

Other Studies

1 other study(ies) available for tosyllysine chloromethyl ketone and Hypertension, Pulmonary

ArticleYear
Increased expression of the cGMP-inhibited cAMP-specific (PDE3) and cGMP binding cGMP-specific (PDE5) phosphodiesterases in models of pulmonary hypertension.
    British journal of pharmacology, 2002, Volume: 137, Issue:8

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Cell Line; Cyclic AMP; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 5; Humans; Hypertension, Pulmonary; Male; Myocytes, Smooth Muscle; Pulmonary Artery; Rats; Rats, Wistar; Tosyllysine Chloromethyl Ketone

2002